Home›Companies›Lhotse Medical

Lhotse Medical, Inc.

Updated Oct 27, 2026·Latest SEC filing May 6, 2025·Suggest an edit

About Lhotse Medical

Lhotse Medical is a private company based in Dallas, Texas, incorporated in 2023 in Delaware. It has reported $3,704,997 raised in two offerings on Form D since January 2024. Its chief executive is Anand Doraiswamy.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 25, 2025May 6, 2025$1,509,999fully sold4$377KEquityRule 506(b)Form D ↗
Dec 22, 2023Jan 4, 2024$2,194,998of $2.2M target7$313KEquityRule 506(b)Form D ↗
Total, two offerings$3,704,997

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lhotse Medical's Form D filed May 6, 2025.

CM
Carter Meyer
Director
Also a director at Rivermark Medical.
CK
Chris Kaster
Director
Also a director at Rivermark Medical.
AD
Anand Doraiswamy
Chief Executive Officer and director
Also an executive officer and director at Rivermark Medical.
JB
Josh Baltzell
Director
Also a director at Rivermark Medical.

Sources

  1. SECLhotse Medical, Inc. filing history